tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BGNE Stock Latest News

BeiGene initiated with an Outperform at JMP Securities
The FlyBeiGene initiated with an Outperform at JMP Securities
2d ago
BGNE
BeiGene shares new Tevimbra data at ESMO 2024
PremiumThe Fly
BeiGene shares new Tevimbra data at ESMO 2024
11d ago
BGNE
BeiGene announces FDA grants Fast Track Designation to BGB-16673
PremiumThe Fly
BeiGene announces FDA grants Fast Track Designation to BGB-16673
25d ago
BGNE
3 Best Stocks to Buy Now, 8/21/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 8/21/2024, According to Top Analysts 
30d ago
BGNE
BeiGene price target raised to $200 from $194 at JPMorgan
PremiumThe Fly
BeiGene price target raised to $200 from $194 at JPMorgan
1M ago
BGNE
BeiGene price target raised to $198 from $181.50 at BofA
PremiumThe FlyBeiGene price target raised to $198 from $181.50 at BofA
1M ago
BGNE
BeiGene price target raised to $288 from $269 at Citi
Premium
The Fly
BeiGene price target raised to $288 from $269 at Citi
1M ago
BGNE
BeiGene reports Q2 GAAP EPS (9c), consensus ($2.15)
Premium
The Fly
BeiGene reports Q2 GAAP EPS (9c), consensus ($2.15)
1M ago
BGNE
BeiGene opens facility in New Jersey
PremiumThe Fly
BeiGene opens facility in New Jersey
2M ago
BGNE
BeiGene Announces New CFO Appointment and Senior Advisor Transition
PremiumCompany Announcements
BeiGene Announces New CFO Appointment and Senior Advisor Transition
2M ago
8K
BGNE
BeiGene names Aaron Rosenberg as CFO, succeeding Julia Wang
PremiumThe Fly
BeiGene names Aaron Rosenberg as CFO, succeeding Julia Wang
2M ago
MRK
BGNE
BeiGene price target lowered to $152.50 from $180 at BofA
PremiumThe Fly
BeiGene price target lowered to $152.50 from $180 at BofA
2M ago
BGNE
BeiGene’s Xiaobin Wu sells over $233K in company shares
PremiumThe FlyBeiGene’s Xiaobin Wu sells over $233K in company shares
3M ago
BGNE
BeiGene to present new data from SEQUOIA study of BRUKINSA
Premium
The Fly
BeiGene to present new data from SEQUOIA study of BRUKINSA
3M ago
BGNE
BeiGene, NewBridge Pharmaceuticals to conclude BRUKINSA pact in MENA
Premium
The Fly
BeiGene, NewBridge Pharmaceuticals to conclude BRUKINSA pact in MENA
3M ago
BGNE
Zymeworks: China NMPA accepts BLA for zanidatamab
PremiumThe Fly
Zymeworks: China NMPA accepts BLA for zanidatamab
3M ago
BGNE
ZYME
BriaCell announces clinical supply agreement with BeiGene
PremiumThe Fly
BriaCell announces clinical supply agreement with BeiGene
4M ago
BCTX
BGNE
BeiGene presents new analyses for BRUKINSA
PremiumThe Fly
BeiGene presents new analyses for BRUKINSA
4M ago
BGNE
BeiGene treatment of membranous nephropathy granted orphan designation
PremiumThe Fly
BeiGene treatment of membranous nephropathy granted orphan designation
4M ago
BGNE
BeiGene initiated with a Buy at Bocom
PremiumThe FlyBeiGene initiated with a Buy at Bocom
4M ago
BGNE
BeiGene price target raised to $254 from $236 at TD Cowen
Premium
The Fly
BeiGene price target raised to $254 from $236 at TD Cowen
4M ago
BGNE
New Risks Emerge for BeiGene: Investors Alerted to Material Updates in Financial Disclosures
Premium
Company Announcements
New Risks Emerge for BeiGene: Investors Alerted to Material Updates in Financial Disclosures
4M ago
BGNE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >